Resources

Update on COVID‑19 Projections

Product: — Science Table

About Coronavirus Epidemiology Vaccine

covid19-sciencetable.ca Last Updated: February 1, 2022

Interleukin‐1 blocking agents for treating COVID‐19

Product: — Cochrane Library

Drug Interventions Treatments

www.cochranelibrary.com Last Updated: January 26, 2022

Also available in Français

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Treatments

covid19-sciencetable.ca Last Updated: January 25, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 21, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 18, 2022

Fluvoxamine: What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 12, 2022

Effectiveness, Use and Re-Use of Masks in Hospitals During the Omicron Wave

Product: — Evidence Synthesis Network

Community Prevention & Transmission Face Protection PPE Public Health & Implementation Transmission

esnetwork.ca Last Updated: January 10, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 8, 2022

Baricitinib for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Hospital Care Treatments

covid19-sciencetable.ca Last Updated: January 8, 2022

Protecting Vulnerable Patients From the COVID‑19 Variant Omicron in Hospital

Product: — Evidence Synthesis Network

Hospital Infection Control Transmission Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Last Updated: January 6, 2022